142 related articles for article (PubMed ID: 34068829)
1. Active Components from
Zheng Y; Yang XW; Schols D; Mori M; Botta B; Chevigné A; Mulinge M; Steinmetz A; Schmit JC; Seguin-Devaux C
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068829
[No Abstract] [Full Text] [Related]
2. Chemical Constituents of
Yang X; He Z; Zheng Y; Wang N; Mulinge M; Schmit JC; Steinmetz A; Seguin-Devaux C
Molecules; 2021 Apr; 26(9):. PubMed ID: 33922460
[TBL] [Abstract][Full Text] [Related]
3. Old plants newly discovered: Cassia sieberiana D.C. and Cassia abbreviata Oliv. Oliv. root extracts inhibit in vitro HIV-1c replication in peripheral blood mononuclear cells (PBMCs) by different modes of action.
Leteane MM; Ngwenya BN; Muzila M; Namushe A; Mwinga J; Musonda R; Moyo S; Mengestu YB; Abegaz BM; Andrae-Marobela K
J Ethnopharmacol; 2012 May; 141(1):48-56. PubMed ID: 22326358
[TBL] [Abstract][Full Text] [Related]
4. A proanthocyanidin-rich extract from Cassia abbreviata exhibits antioxidant and hepatoprotective activities in vivo.
Sobeh M; Mahmoud MF; Abdelfattah MAO; Cheng H; El-Shazly AM; Wink M
J Ethnopharmacol; 2018 Mar; 213():38-47. PubMed ID: 29126990
[TBL] [Abstract][Full Text] [Related]
5. In Silico Identification of Novel Aromatic Compounds as Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4.
Andrianov AM; Nikolaev GI; Kornoushenko YV; Xu W; Jiang S; Tuzikov AV
Viruses; 2019 Aug; 11(8):. PubMed ID: 31412617
[TBL] [Abstract][Full Text] [Related]
6. ent-Epiafzelechin-(4alpha-->8)-epiafzelechin extracted from Cassia javanica inhibits herpes simplex virus type 2 replication.
Cheng HY; Yang CM; Lin TC; Shieh DE; Lin CC
J Med Microbiol; 2006 Feb; 55(Pt 2):201-206. PubMed ID: 16434713
[TBL] [Abstract][Full Text] [Related]
7. HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor.
Bashir T; Patgaonkar M; Kumar SC; Pasi A; Reddy KV
PLoS One; 2015; 10(4):e0124839. PubMed ID: 25915507
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.
Curreli F; Haque K; Xie L; Qiu Q; Xu J; Yong W; Tong X; Debnath AK
Bioorg Med Chem; 2015 Dec; 23(24):7618-28. PubMed ID: 26602829
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Reversible and Time-Dependent CYP450 Inhibition Profiles of Medicinal Herbal Plant Extracts Newbouldia laevis and Cassia abbreviata: Implications for Herb-Drug Interactions.
Thomford NE; Dzobo K; Chopera D; Wonkam A; Maroyi A; Blackhurst D; Dandara C
Molecules; 2016 Jul; 21(7):. PubMed ID: 27399660
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections.
Sepúlveda-Crespo D; Ceña-Díez R; Jiménez JL; Ángeles Muñoz-Fernández M
Med Res Rev; 2017 Jan; 37(1):149-179. PubMed ID: 27518199
[TBL] [Abstract][Full Text] [Related]
11. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal Effect and Anti-Inflammatory Activity of
Panthong S; Itharat A; Naknarin S; Kuropakornpong P; Ooraikul B; Sakpakdeejaroen I
ScientificWorldJournal; 2020; 2020():1653180. PubMed ID: 32765193
[TBL] [Abstract][Full Text] [Related]
13. A broad spectrum anti-HIV inhibitor significantly disturbs V1/V2 domain rearrangements of HIV-1 gp120 and inhibits virus entry.
Berinyuy E; Soliman ME
J Recept Signal Transduct Res; 2016; 36(2):119-29. PubMed ID: 26446906
[TBL] [Abstract][Full Text] [Related]
14. HIV type-1 entry inhibitors with a new mode of action.
Fink RC; Roschek B; Alberte RS
Antivir Chem Chemother; 2009; 19(6):243-55. PubMed ID: 19641233
[TBL] [Abstract][Full Text] [Related]
15. The Myxobacterial Metabolite Soraphen A Inhibits HIV-1 by Reducing Virus Production and Altering Virion Composition.
Fleta-Soriano E; Smutná K; Martínez JP; Lorca Oró C; Sadiq SK; Mirambeau G; Lopez-Iglesias C; Bosch M; Pol A; Brönstrup M; Diez J; Meyerhans A
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533249
[TBL] [Abstract][Full Text] [Related]
16. Lobostemon trigonus (Thunb.) H. Buek, a medicinal plant from South Africa as a potential natural microbicide against HIV-1.
Chawuke P; van den Berg N; Fouche G; Maharaj V; Shoko T; Johan van der Westhuizen C; Invernizzi L; Alexandre KB
J Ethnopharmacol; 2021 Sep; 277():114222. PubMed ID: 34033901
[TBL] [Abstract][Full Text] [Related]
17. The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition.
Reiser K; Mathys L; Curbo S; Pannecouque C; Noppen S; Liekens S; Engman L; Lundberg M; Balzarini J; Karlsson A
PLoS One; 2016; 11(1):e0147773. PubMed ID: 26816344
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 infection in ex vivo cervical tissue model of human vagina by palmitic acid; implications for a microbicide development.
Lin X; Paskaleva EE; Chang W; Shekhtman A; Canki M
PLoS One; 2011; 6(9):e24803. PubMed ID: 21949756
[TBL] [Abstract][Full Text] [Related]
19. A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection.
Yang J; Li L; Tan S; Jin H; Qiu J; Mao Q; Li R; Xia C; Jiang ZH; Jiang S; Liu S
Fitoterapia; 2012 Mar; 83(2):348-55. PubMed ID: 22155187
[TBL] [Abstract][Full Text] [Related]
20. In vitro antifungal activity of cassia fistula extracts against fluconazole resistant strains of Candida species from HIV patients.
Sony P; Kalyani M; Jeyakumari D; Kannan I; Sukumar RG
J Mycol Med; 2018 Mar; 28(1):193-200. PubMed ID: 28838629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
